Daniel Moritz has over 11 years of
rich experience in the pharmaceutical
industry, specializing in Real-World
Data Strategy, External Research and
Digital Partnerships, and Innovation
Excellence. Daniel's in-house
experience in pharmaceuticals is
market by his tenure at Bristol Myers
Squibb, where he progressively
advanced the RWD Strategy for the
organization during accelerated
growth. Throughout his career, Daniel
has demonstrated expertise in alliance
management, real-world data
exploration, data acquisition
transactions, search and evaluation,
sourcing, negotiations and wide
variety of services. Daniel has
led cross-functional teams across
various research functions
departments, managing research and
innovation programs across therapeutic
areas, impacting 40+ indications in
over 15 countries. Daniel has also
evaluated and consulted on over 20
data companies, which helped lead to
faster clinical trial site selection
and 200+ real-world evidence
projects. Daniel has also helped
streamlined processes in digital
health, data strategy, and AI/ML
across R&D pilot projects,
managing 100% year-over-year growth,
in categories reaching $200M per year,
designed processes for assessing data
quality KPIs and privacy compliance
for 50+ data providers, enhancing
pre-clinical, clinical, and commercial
operations. This experience is coupled
with managing partnership budgets over
$150M, securing advantageous
partnership terms resulting in 20%
cost savings, and ensured successful
partnerships across dozens of
alliances. Daniel’s career is
characterized by his strategic
thinking, problem-solving abilities,
and a consistent track record of
fostering significant alliances and
optimizing operational efficiencies
within the pharmaceutical sector.